Trial Profile
A Study of Blood-Borne Autologous Angiogenic Cells Precursors Therapy in Patients With Critical Limb Ischemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs ACP 01 (Primary)
- Indications Chronic limb-threatening ischemia; Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms ACPs-CLI
- Sponsors TheraVitae
- 04 Jun 2014 New trial record